Archive for the ‘News’ Category

Many African-Americans Avoid Mammograms Due To Fear, Misconceptions About Screenings

Training physicians and caregivers to improve cultural sensitivity and communication with economically disadvantaged African-American patients could influence these women to get mammograms that could save their lives, according to a new study in the Journal of General Internal Medicine. The study...
November 13th, 2008 | News | Read More

Breast Cancer Screening Could Be Revolutionized By New Technology

The world’s first radar breast imaging system developed at Bristol University that could revolutionise the way women are scanned for breast cancer, is being trialled at North Bristol NHS Trust (NBT). Professor Alan Preece and Dr Ian Craddock from the University of Bristol have been working for...
November 12th, 2008 | News | Read More

The Genetics Of Breast Cancer Studied Using New Technique

A new technique to study genetic changes that can lead to breast cancer could be one step closer. The University of Nottingham has received £15,000 from the charity Breast Cancer Campaign to fill in one of the research gaps identified by the country’s top breast cancer experts in a recent...
November 12th, 2008 | News | Read More

News From The Journal Of The National Cancer Institute, Nov. 11

Overexpression of OLC1 Gene Associated with Smoking-Related Lung Cancer The Overexpressed in Lung Cancer 1 (OLC1) gene is expressed at high levels in the majority of lung cancers, more often in samples from smokers than nonsmokers, and its expression is increased in cells treated with cigarette smoke....
November 12th, 2008 | News | Read More

No Association Between Calcium Plus Vitamin D Supplementation And Reduced Breast Cancer Risk

Taking calcium and vitamin D supplements does not reduce breast cancer incidence in postmenopausal women, according to data from a randomized, doubled-blind, placebo-controlled trial published online November 11 in the Journal of the National Cancer Institute. Several observational and preclinical...
November 12th, 2008 | News | Read More

DxS Expand Their Portfolio Of Cancer Mutation Products, With The Launch Of A PI3K Mutation Detection Kit

DxS, a personalised medicine company and market leaders in the provision of companion diagnostics are pleased to announce the addition of a PI3K Mutation Detection Kit to their portfolio of oncogene mutation products. PI3K is a biomarker assessed during the evaluation of the tyrosine kinase inhibitors...
November 11th, 2008 | News | Read More

Caffeine & Skin Cancer Prevention

The most important risk factor for development of skin cancer is exposure to UV rays, mainly from sunlight. The UV radiation damages the DNA in the skin cells. The damaged cells grow and divide uncontrollably, leading to the development of a tumor. Researchers are now looking for ways to reverse the...
November 11th, 2008 | Cancer Research, News | Read More

Vitamin K2 Cuts Prostate Cancer Risk – The Anti-Aging Bottom Line

Men with the highest intake of vitamin K2, also known as menaquinone, had only about one-third the risk of developing advanced prostate cancer compared to men with low intake of the vitamin, new research by German scientists shows. Vitamin K2 is synthesized by bacteria in our guts. It is also found in...
November 11th, 2008 | News, Prevention | Read More

Primary Care Visits For Breast Symptoms And The Frequency Of Cancer Diagnosis

A study of 84,285 women seeking care in Dutch family physician offices between 1985 and 2003 revealed that breast symptoms were reported in about 3 percent of all visits. Of the women complaining of breast symptoms, 3 percent of those women were subsequently diagnosed with breast cancer. Notably, those...
November 11th, 2008 | News | Read More

Karmanos Cancer Institute Seeks Breast Cancer Patients To Participate In A New Drug Trial

The Barbara Ann Karmanos Institute is looking for women with HER2 positive metastatic breast cancer to participate in a clinical trial. The Phase II trial at Karmanos is part of an international study to further test a new drug Trastuzumab-DM1, in development by Genentech. The ...
November 11th, 2008 | News | Read More